Document Detail


Transurethral Resection of Prostate and the Role of Pharmacological Treatment with Dutasteride in Decreasing Surgical Blood Loss.
MedLine Citation:
PMID:  23030716     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Purpose: Transurethral resection of prostate (TURP) still represents the gold standard in the surgical treatment of symptomatic benign prostatic hyperplasia (BPH). The most frequent complication is represented by intra- and perioperative bleeding. Preoperative use of 5-alpha-reductase inhibitors (finasteride or dutasteride) to reduce surgical bleeding is still a topic of debate in literature. Previous studies provided favorable data on blood loss reduction by preoperative administration of finasteride or dutasteride. The aim of this study was to evaluate whether pretreatment with dutasteride for six weeks before surgery can reduce surgical blood loss. Methods: A total of 142 patients with BPH-who were to undergo TURP-were enrolled and randomized into two groups. The dutasteride group comprising of 71 patients, was treated with dutasteride (0.5 mg/day) for 6 weeks before surgery and the control group, comprising of other 71 patients, did not receive dutasteride. Blood loss was evaluated in terms of a reduction in the serum hemoglobin level (ΔHb and ΔHCT), and was estimated by measuring the Hb and hematocrit levels before and 24 hours after surgery. Results: None of the patients treated with dutasteride reported any side effects. A significantly lower mean blood loss was observed in the dutasteride group compared to the control group (ΔHb=-1.29±0.81 v -1.83±1.25, respectively, p<0.0027; ΔHCT=-5.67±2.58 v -6.50±2.40, respectively, p<0.0491). Conclusions: Our results showed that pretreatment with dutasteride for 6 weeks before TURP reduces the surgical bleeding considerably. This treatment schedule can be used routinely to decrease TURP surgical bleeding.
Authors:
Antonio Luigi Pastore; Simone Mariani; Francesco Barrese; Giovanni Palleschi; Armando Manuel Valentini; Luca Pacini; Vincenzo Petrozza; Antonio Carbone; Manlio Cappa
Related Documents :
24073316 - What is the most effective drug delivery system for cisplatin during the treatment of h...
24656636 - Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer...
11123176 - Dynamic assessment of imbalance in acoustic neuroma patients by sway magnetometry
24354616 - Autologous platelet rich plasma: topical versus intradermal after fractional ablative c...
10355166 - The long-term effect of yag laser posterior capsulotomy on intraocular pressure after c...
25236536 - Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles re...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-3
Journal Detail:
Title:  Journal of endourology / Endourological Society     Volume:  -     ISSN:  1557-900X     ISO Abbreviation:  J. Endourol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807503     Medline TA:  J Endourol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Unit of Urology, Department of Medical and Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, Sapienza University of Rome , Latina (LT), Italy .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Palladium-catalyzed diastereo- and enantioselective formal [3 + 2]-cycloadditions of substituted vin...
Next Document:  Neuropeptides and Epitheliopeptides: Structural and Functional Diversity in an Ancestral Metazoan Hy...